Select Medical Holdings Management

Management Kriterienprüfungen 1/4

Select Medical Holdings' CEO ist David Chernow , ernannt in Jan 2014, hat eine Amtszeit von 10.42 Jahren. Die jährliche Gesamtvergütung beträgt $10.71M , bestehend aus 9.3% Gehalt und 90.7% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.9% der Aktien des Unternehmens, im Wert von $40.11M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 1.3 Jahre bzw. 14.8 Jahre.

Wichtige Informationen

David Chernow

Geschäftsführender

US$10.7m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	9.3%
Amtszeit als Geschäftsführer	10.4yrs
Eigentum des Geschäftsführers	0.9%
Durchschnittliche Amtszeit des Managements	1.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	14.8yrs

Jüngste Management Updates

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Apr 19

Recent updates

Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

Jun 13

There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price

May 26

Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

May 05

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Apr 19

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Apr 11

Select Medical: Solid Growth Prospects And A Compelling Valuation

Mar 05

Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

Feb 18

Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors

Oct 25

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Oct 04

Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Sep 16

Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold

Aug 11

Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Aug 07

Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

Jul 14

At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?

Jun 29

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

May 27

Select Medical: Revising To Hold As Business Economics Roll Lower

May 26

Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital

Apr 05

Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?

Mar 17

Select Medical GAAP EPS of $0.22 misses by $0.11, revenue of $1.58B in-line

Feb 23

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

Jan 31

The Returns On Capital At Select Medical Holdings (NYSE:SEM) Don't Inspire Confidence

Dec 20

Is Now An Opportune Moment To Examine Select Medical Holdings Corporation (NYSE:SEM)?

Dec 01

Select Medical declares $0.125 dividend

Nov 03

These 4 Measures Indicate That Select Medical Holdings (NYSE:SEM) Is Using Debt Extensively

Nov 01

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Sep 16

Select Medical: Adding To Position For Further Upside Capture

Sep 14

Calculating The Fair Value Of Select Medical Holdings Corporation (NYSE:SEM)

Aug 31

Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Aug 10

Select Medical down 9% on Q2 profit miss, reiterates full-year forecast

Aug 05

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von David Chernow im Vergleich zu den Einnahmen von Select Medical Holdings verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Mar 31 2024	n/a	n/a	US$260m
Dec 31 2023	US$11m	US$995k	US$235m
Sep 30 2023	n/a	n/a	US$217m
Jun 30 2023	n/a	n/a	US$196m
Mar 31 2023	n/a	n/a	US$174m
Dec 31 2022	US$9m	US$995k	US$153m
Sep 30 2022	n/a	n/a	US$175m
Jun 30 2022	n/a	n/a	US$223m
Mar 31 2022	n/a	n/a	US$329m
Dec 31 2021	US$12m	US$995k	US$389m
Sep 30 2021	n/a	n/a	US$415m
Jun 30 2021	n/a	n/a	US$415m
Mar 31 2021	n/a	n/a	US$306m
Dec 31 2020	US$8m	US$995k	US$250m
Sep 30 2020	n/a	n/a	US$206m
Jun 30 2020	n/a	n/a	US$162m
Mar 31 2020	n/a	n/a	US$155m
Dec 31 2019	US$8m	US$995k	US$143m
Sep 30 2019	n/a	n/a	US$136m
Jun 30 2019	n/a	n/a	US$138m
Mar 31 2019	n/a	n/a	US$140m
Dec 31 2018	US$8m	US$995k	US$133m
Sep 30 2018	n/a	n/a	US$207m
Jun 30 2018	n/a	n/a	US$193m
Mar 31 2018	n/a	n/a	US$189m
Dec 31 2017	US$7m	US$984k	US$171m

Vergütung im Vergleich zum Markt: DavidDie Gesamtvergütung ($USD10.71M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD6.83M).

Entschädigung vs. Einkommen: DavidDie Bezüge der Mitarbeiter sind im vergangenen Jahr um mehr als 20 % gestiegen.

Geschäftsführer

David Chernow (67 yo)

10.4yrs

Amtszeit

US$10,706,265

Vergütung

Mr. David S. Chernow serves as Director at Exokinetics, Inc. He has been the Chief Executive Officer at Select Medical Holdings Corporation and Select Medical Corporation since January 1, 2014. Mr. Chernow...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Robert Ortenzio	Co-Founder & Executive Chairman	19.3yrs	US$10.77m	6.95% $ 307.3m
David Chernow	Chief Executive Officer	10.4yrs	US$10.71m	0.90% $ 39.8m
Rocco Ortenzio	Co-Founder & Vice Chairman	19.4yrs	US$7.08m	6.04% $ 267.2m
Michael Malatesta	Executive VP & CFO	less than a year	US$1.53m	0.15% $ 6.8m
Michael Tarvin	Senior Executive VP	27.3yrs	US$4.44m	0.41% $ 18.0m
Martin Jackson	Senior Executive Vice President of Strategic Finance & Operations	less than a year	US$6.47m	1.07% $ 47.2m
John Saich	Co-President	less than a year	keine Daten	0.55% $ 24.5m
Thomas Mullin	Co-President	less than a year	keine Daten	0.30% $ 13.4m
Christopher Weigl	Senior VP	1.3yrs	keine Daten	0.031% $ 1.4m
Brian Rusignuolo	Executive VP & Chief Information Officer	3.4yrs	keine Daten	0.28% $ 12.2m
Robert Breighner	Senior Vice President of Compliance & Audit	no data	keine Daten	0.029% $ 1.3m
Shelly Eckenroth	Senior VP & Chief Communications	less than a year	keine Daten	keine Daten

1.3yrs

Durchschnittliche Betriebszugehörigkeit

55yo

Durchschnittliches Alter

Erfahrenes Management: SEMDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.3 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Robert Ortenzio	Co-Founder & Executive Chairman	19.3yrs	US$10.77m	6.95% $ 307.3m
Rocco Ortenzio	Co-Founder & Vice Chairman	19.4yrs	US$7.08m	6.04% $ 267.2m
Russell Carson	Independent Lead Director	19.3yrs	US$384.40k	0.84% $ 37.3m
Thomas Scully	Independent Director	20.3yrs	US$383.40k	0.069% $ 3.0m
Daniel Thomas	Independent Director	4.9yrs	US$405.80k	0.051% $ 2.2m
William Frist	Independent Director	14.1yrs	US$407.83k	0.22% $ 9.7m
Marilyn Tavenner	Independent Director	5.6yrs	US$394.40k	0.042% $ 1.8m
James Ely	Independent Director	15.6yrs	US$414.83k	0.11% $ 5.0m
Katherine Davisson	Independent Director	3.2yrs	US$409.80k	0.035% $ 1.6m
Parvinderjit Khanuja	Independent Director	2.6yrs	US$407.83k	0.033% $ 1.5m

14.8yrs

Durchschnittliche Betriebszugehörigkeit

66yo

Durchschnittliches Alter

Erfahrener Vorstand: SEMDie Vorstandsmitglieder sind sehr erfahren ( 14.8 ).

Select Medical Holdings Management

Management Kriterienprüfungen 1/4

Wichtige Informationen

Jüngste Management Updates

Insufficient new directors

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings Corporation, Annual General Meeting, Apr 25, 2024

Co-Founder & Executive Chairman notifies of intention to sell stock

Co-Founder & Executive Chairman notifies of intention to sell stock

Recent updates

Does Select Medical Holdings (NYSE:SEM) Have A Healthy Balance Sheet?

There's Reason For Concern Over Select Medical Holdings Corporation's (NYSE:SEM) Price

Price target increased by 8.9% to US$39.00

Investor sentiment improves as stock rises 17%

First quarter dividend of US$0.13 announced

Results: Select Medical Holdings Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

New minor risk - Shareholder dilution

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Select Medical Reaffirms Earnings Guidance for the Year 2024

Insufficient new directors

Here's Why Shareholders Should Examine Select Medical Holdings Corporation's (NYSE:SEM) CEO Compensation Package More Closely

Returns At Select Medical Holdings (NYSE:SEM) Appear To Be Weighed Down

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings Corporation to Report Q1, 2024 Results on May 02, 2024

Select Medical Holdings Corporation, Annual General Meeting, Apr 25, 2024

Co-Founder & Executive Chairman notifies of intention to sell stock

Price target increased by 7.5% to US$35.80

Select Medical: Solid Growth Prospects And A Compelling Valuation

Fourth quarter dividend of US$0.13 announced

Full year 2023 earnings: EPS misses analyst expectations

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About March 13, 2024

Cautious Investors Not Rewarding Select Medical Holdings Corporation's (NYSE:SEM) Performance Completely

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings Corporation to Report Q4, 2023 Results on Feb 22, 2024

We Think Select Medical Holdings (NYSE:SEM) Is Taking Some Risk With Its Debt

Co-Founder & Executive Chairman notifies of intention to sell stock

Returns On Capital At Select Medical Holdings (NYSE:SEM) Have Hit The Brakes

Co-Founder & Executive Chairman notifies of intention to sell stock

Upcoming dividend of US$0.13 per share at 2.3% yield

Select Medical Holdings (NYSE:SEM) Is Due To Pay A Dividend Of $0.125

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About November 28, 2023

Select Medical: Market Expectations Appear Well Justified With Technical And Economic Factors

Select Medical Holdings Corporation to Report Q3, 2023 Results on Nov 02, 2023

What Does Select Medical Holdings Corporation's (NYSE:SEM) Share Price Indicate?

Is Select Medical Holdings (NYSE:SEM) Using Too Much Debt?

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings Corporation Announces Appointment of Michael Malatesta as Chief Financial Officer, Effective October 1, 2023

Select Medical Holdings Corporation Announces Appointment of Michael Malatesta as Chief Financial Officer, Effective October 1, 2023

Select Medical: Capital Charge Now $6.1Bn At C.6% Trailing Returns, Reiterate Hold

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings (NYSE:SEM) Will Pay A Dividend Of $0.125

Second quarter 2023 earnings: EPS exceeds analyst expectations

Select Medical Holdings Corporation Announces Cash Dividend, Payable on or about September 1, 2023

Select Medical Holdings Corporation Provides Earnings Guidance for the Second Quarter Ended June 30, 2023

Select Medical Holdings (NYSE:SEM) Has More To Do To Multiply In Value Going Forward

Co-Founder & Executive Chairman notifies of intention to sell stock

Select Medical Holdings Corporation to Report Q2, 2023 Results on Aug 03, 2023

Co-Founder & Executive Chairman notifies of intention to sell stock

At US$31.69, Is Select Medical Holdings Corporation (NYSE:SEM) Worth Looking At Closely?

Select Medical Holdings Corporation(NYSE:SEM) dropped from Russell Small Cap Comp Value Index

Co-Founder & Executive Chairman notifies of intention to sell stock

Co-Founder & Executive Chairman notifies of intention to sell stock

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden

Select Medical: Revising To Hold As Business Economics Roll Lower

Co-Founder & Executive Chairman notifies of intention to sell stock

Insider recently sold US$296k worth of stock

Upcoming dividend of US$0.13 per share at 1.7% yield

Price target increased by 7.8% to US$35.80

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Select Medical Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of 2023

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About May 31, 2023

Select Medical Holdings (NYSE:SEM) May Have Issues Allocating Its Capital

Should You Investigate Select Medical Holdings Corporation (NYSE:SEM) At US$25.73?

President & CEO notifies of intention to sell stock

Full year 2022 earnings: EPS misses analyst expectations

Select Medical GAAP EPS of $0.22 misses by $0.11, revenue of $1.58B in-line

Select Medical Holdings Corporation to Report Q4, 2022 Results on Feb 23, 2023

Here's Why Select Medical Holdings (NYSE:SEM) Has A Meaningful Debt Burden